IVF denied as duplicate or overlapping therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Issues "Duplicate Therapy" Denials for IVF — and How to Appeal

A "duplicate therapy" denial from a BlueCross BlueShield plan in the context of IVF most commonly arises in one of two situations: (1) BCBS has determined that a current or recently authorized fertility treatment overlaps with the IVF cycle being requested — for example, an active IUI authorization, an ongoing gonadotropin prescription, or a prior IVF cycle authorization still open in their system — or (2) where coordination-of-benefits rules between two insurance plans result in one plan flagging the claim as already covered by the other. Understanding which scenario applies is the critical first step.

BCBS plans vary significantly by state and by employer contract, so "duplicate therapy" criteria are not uniform across all BCBS affiliates. Always obtain your specific BCBS affiliate's medical policy document before drafting your appeal.

## Your Federal Appeal Rights

• Internal appeal: Under ERISA §503 (self-funded plans) or applicable state insurance law (fully insured plans), you have the right to a full internal review. Request the specific clinical or administrative basis for the duplicate-therapy determination in writing.
• External review (ACA §2719): After exhausting internal appeals, you may request independent external review within approximately 4 months (180 days) of the denial. Expedited review is available if delay poses a medical risk.

## The Concrete Appeal Process

1. Clarify the basis for the denial: Ask BCBS in writing whether the "duplicate therapy" finding is clinical (overlapping treatments) or administrative (COB with another plan). The appeal strategy differs significantly. 2. For clinical duplicates: Obtain documentation from your reproductive endocrinologist confirming that the prior or concurrent treatment authorization has concluded, or that IVF and the flagged treatment are not being pursued simultaneously. 3. For COB duplicates: Confirm which plan is primary and which is secondary, and provide BCBS with the primary plan's Explanation of Benefits (EOB) showing what was or was not paid. 4. Submit a Level 1 internal appeal with a prescriber letter clarifying the treatment sequence and a chronological treatment timeline. 5. Escalate to external review if the internal appeal is upheld.

## Documentation to Gather

• Treatment timeline: A clear, dated chronological record of all fertility treatments — showing that any previously authorized treatment has been completed or discontinued, and that IVF is the current distinct course of treatment.
• Prescriber letter: A letter from your reproductive endocrinologist confirming the clinical rationale for IVF as a new, non-duplicative treatment course and documenting the outcome of any prior treatment.
• Prior authorization records: Copies of prior PA approvals and their termination or expiration dates, to demonstrate the prior authorization is no longer active.
• COB documentation (if applicable): Your primary insurer's EOB and your BCBS coordination-of-benefits election form.
• BCBS medical policy: Your specific BCBS affiliate's current IVF or infertility coverage policy, obtained from your BCBS member portal.

## Criteria-Mapping Structure

Address the duplicate-therapy finding directly: identify what BCBS claims is duplicative, show with dated documentation that the overlap either does not exist or has been resolved, and confirm your prescriber's clinical rationale for why IVF is the appropriate current treatment. A clear timeline is often the single most persuasive document in a duplicate-therapy appeal.